WHO ICTRP trial
Is progression of arteriosclerosis in ESRD patients inhibited by nocturnal…
NL-OMON47285 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON47285 |
|---|---|
| Public title | Is progression of arteriosclerosis in ESRD patients inhibited by nocturnal hemodialysis of renal transplantation? |
| Scientific title | Is progression of arteriosclerosis in ESRD patients inhibited by nocturnal hemodialysis of renal transplantation? - Nocturnal hemodialysis and arteriosclerosis |
| Primary sponsor | Dianet Dialysecentra |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Observational invasive |
| Countries | The Netherlands |
| Conditions | cardiovascular disease in hemodialysis patients; vascular calcification in patients with end-stage renal disease;10011082;10029149;10003216;cardiovascular disease in hemodialysis patients; vascular calcification in patients with end-stage… |
| Interventions | ;arterial calcification;multi-slice CT;nocturnal hemodialysis;renal transplantation |
| Registration date | Mar 13, 2018 |
| Target size | 180 |
| Secondary IDs | NCT00950573;NL18314.041.08 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: